Infantile Spasms
📧 Sign up to get email alerts when something new happens for Infantile Spasms.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-12-11FDA Approved: SABRIL — Supplemental Application (Lundbeck Pharmaceuticals LLC)
FDA approved a supplemental application for SABRIL (vigabatrin) from Lundbeck Pharmaceuticals LLC. The action typically updates labeling or …
-
FDA approval · 2011-01-18FDA Approved: SABRIL — Supplemental Application (Lundbeck Pharmaceuticals LLC)
FDA approved a supplemental application for Sabril (vigabatrin) submitted by Lundbeck Pharmaceuticals LLC.
-
FDA approval · 2011-01-18FDA Approved: SABRIL — Supplemental Application (Lundbeck Pharmaceuticals LLC)
FDA approved a supplemental application for Sabril (vigabatrin) submitted by Lundbeck Pharmaceuticals LLC.
-
FDA approval · 2009-08-21FDA Approved: SABRIL — Original Application (Lundbeck Pharmaceuticals LLC)
FDA approved Sabril (vigabatrin) from Lundbeck as an original NDA for the treatment of infantile spasms and refractory complex partial seizu…
-
FDA approval · 2009-08-21FDA Approved: SABRIL — Original Application (Lundbeck Pharmaceuticals LLC)
FDA approved the original application for Sabril (vigabatrin), marking its initial authorization for infantile spasms.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.